Your first day taking semaglutide: what actually happens

The 0.25mg starting dose is a tolerability dose: its job is to let your body settle in, not to produce rapid weight loss from day one.
Gastrointestinal effects (mild nausea, queasiness or loose stools) are common in the first few days and tend to ease within one to two weeks.
Most people notice no dramatic change in appetite on day one; the appetite-reducing effect builds as the dose increases over several weeks.
Semaglutide is a prescription-only medicine: a GPhC-registered Independent Prescriber reviews your consultation before treatment is dispensed.

The morning you take your first dose of semaglutide, most people feel almost nothing out of the ordinary — and that is completely normal. Semaglutide works gradually; the 0.25mg starting dose is low by design, giving your system time to adjust before any increase. That said, knowing what to watch for, and what to ignore, makes the first day taking Wegovy or any semaglutide-based treatment considerably less anxious. These are prescription-only medicines, and a GPhC-registered prescriber will have assessed your suitability before your pen arrives — so if you have specific questions about your own circumstances, your clinical team is the right place to start.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What your body is doing on day one, and how to make it easier

The scene: pen in hand, leaflet on the table, wondering what comes next

You have read the Patient Information Leaflet, chosen your injection site, and administered the first 0.25mg dose. Now you are waiting. For most people, the honest answer is that not much happens in the first few hours. Semaglutide is a GLP-1 receptor agonist that works by mimicking a gut hormone released after eating, slowing gastric emptying, nudging the brain toward fullness, and steadying blood sugar. None of that happens in a single afternoon.

What you might notice is a faint awareness around the stomach: not pain, but a kind of mild fullness or low-level queasiness, particularly if you ate a larger meal before or shortly after the injection. Some people feel nothing at all on day one. Both responses are well within the range reported in clinical studies. The Wegovy programme has been through extensive trials, and the 0.25mg starting dose specifically exists because researchers found it greatly reduces the chance of severe nausea early on. Think of it less as a treatment dose and more as an introduction.

Timing your first injection matters more than people expect. Many prescribers suggest the evening of a quieter day, so that any stomach unsettledness happens while you are resting rather than in a meeting. If you ordered mid-week, taking the first dose on a Thursday or Friday means the weekend is available for rest if needed, rather than, say, the morning of a busy Monday commute.

Side effects that are common on day one (and what to do about them)

The NHS medicines page for semaglutide lists nausea as the most frequently reported side effect, particularly in the early weeks. On day one, if it appears, it tends to be mild, a background queasiness rather than vomiting. Other people report burping, a feeling of fullness that lingers, or slightly looser stools in the day following the injection. Fatigue shows up less often but is not unusual.

Practical things that genuinely help: eat smaller portions than usual and favour lower-fat, lower-spice foods. Semaglutide slows how quickly your stomach empties, so a large or rich meal on injection day makes nausea more likely. Keep fluids up, plain water is ideal. Avoid alcohol for the first couple of days. If nausea arrives, eating a dry cracker or a piece of toast rather than pushing through a full meal usually does more than any over-the-counter remedy. These adjustments are well-established enough that the first day of Wegovy guidance our clinical team provides covers them specifically.

Symptoms that should prompt you to contact a clinician rather than wait: severe stomach pain that radiates toward the back (which can be a sign of pancreatic inflammation, the MHRA highlighted this risk in its January 2026 Drug Safety Update for GLP-1 medicines), signs of an allergic reaction such as swelling or breathing difficulty, or anything that feels disproportionate to a low starting dose. For anything less urgent, our aftercare team is available seven days a week.

What day one does not tell you about how well semaglutide will work for you

Here is the part that surprises many people when taking Wegovy for the first time: day one is a genuinely poor predictor of your experience. The appetite-dampening effect that most patients describe (food feeling less compelling, portion sizes shrinking naturally) typically takes several weeks to become noticeable, once the dose has been titrated upward from 0.25mg through 0.5mg toward the higher maintenance doses. Patients who feel nothing on day one sometimes become those who find the medicine transforms their relationship with food by week eight. The reverse is also true: a rough first day does not mean the treatment will be intolerable long-term.

In the STEP 1 trial, published in the New England Journal of Medicine, participants taking semaglutide 2.4mg achieved an average weight reduction of around 15% over 68 weeks. That outcome is built across an entire titration journey, not on the first injection. Weight loss from semaglutide is a cumulative process. Day one is simply the first data point in a much longer picture, and it counts.

If you are wondering how this first day compares for a tablet-based route, our pages on taking Wegovy cover both the injection and the newer oral option, so you can understand how the starting experience differs between formats. The Wegovy first-time guide goes into more depth on what the first few weeks look like across the titration schedule.

Tracking what happens, and when to raise it with a prescriber

Keeping a brief daily note during the first week costs almost no time and pays off considerably at your first clinical review. Note when you injected, what you ate nearby, whether any nausea or other GI effects appeared, how long they lasted, and whether they affected your usual routine. That information helps a prescriber decide whether the titration schedule is right for you, or whether slowing the pace would serve you better.

If you are considering starting semaglutide and want to understand the full picture before committing, our weight loss treatment overview covers eligibility, what the titration schedule involves, and how the process works through a regulated UK pharmacy. You can also read more about our clinical team on the prescriber profile page. Semaglutide is a prescription-only medicine: a named prescriber, not software, reads every consultation before treatment is approved and dispatched. If day one raises questions your leaflet does not answer, our support team is there. And if you have not yet started but are weighing your options, you can check your eligibility through a free consultation, reviewed the same day it's submitted.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions